[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review

March 2021 | 50 pages | ID: HE041B056B5EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets instruments, consumables, systems and software. The company’s products include spectrophotometers, plate readers, gel electrophoresis equipment, amino acid analyzers, electroporation and electrofusion instruments, wireless monitors, data acquisition and analysis products and software, and syringe pump and peristaltic pumps, among others. It also provides data analysis, training and installation services. Harvard Bioscience serves research scientists at pharmaceutical and biotechnology companies, hospitals, universities, government laboratories, and contract research organizations. The company markets products directly in the US, the UK, Germany, France, Sweden, Canada, Italy, Spain and China; and also through a network of distributors in other countries. Harvard Bioscience is headquartered in Holliston, Massachusetts, the US.

Harvard Bioscience Inc Key Recent Developments

Feb 18,2021: Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
Dec 22,2020: Harvard Bioscience announces new credit facility
Nov 05,2020: Harvard Bioscience announces third quarter 2020 financial results
Aug 05,2020: Harvard Bioscience announces second quarter 2020 financial results
Jul 20,2020: Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Harvard Bioscience Inc - Key Facts
Harvard Bioscience Inc - Key Employees
Harvard Bioscience Inc - Key Employee Biographies
Harvard Bioscience Inc - Major Products and Services
Harvard Bioscience Inc - History
Harvard Bioscience Inc - Company Statement
Harvard Bioscience Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Harvard Bioscience Inc - Business Description
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
Harvard Bioscience Inc - Corporate Strategy
Harvard Bioscience Inc - SWOT Analysis
SWOT Analysis - Overview
Harvard Bioscience Inc - Strengths
Harvard Bioscience Inc - Weaknesses
Harvard Bioscience Inc - Opportunities
Harvard Bioscience Inc - Threats
Harvard Bioscience Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Harvard Bioscience Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Harvard Bioscience Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 18, 2021: Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
Dec 22, 2020: Harvard Bioscience announces new credit facility
Nov 05, 2020: Harvard Bioscience announces third quarter 2020 financial results
Aug 05, 2020: Harvard Bioscience announces second quarter 2020 financial results
Jul 20, 2020: Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET
May 05, 2020: Harvard Bioscience announces first quarter 2020 financial results
Apr 18, 2020: HARVARD BIOSCIENCE receives loan under Paycheck Protection Program
Apr 06, 2020: Harvard Bioscience announces appointment of Susan Steele to board of directors
Feb 26, 2020: Harvard Bioscience announces fourth quarter 2019 financial results
Feb 11, 2020: Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Harvard Bioscience Inc, Key Facts
Harvard Bioscience Inc, Key Employees
Harvard Bioscience Inc, Key Employee Biographies
Harvard Bioscience Inc, Major Products and Services
Harvard Bioscience Inc, History
Harvard Bioscience Inc, Subsidiaries
Harvard Bioscience Inc, Key Competitors
Harvard Bioscience Inc, Ratios based on current share price
Harvard Bioscience Inc, Annual Ratios
Harvard Bioscience Inc, Annual Ratios (Cont...1)
Harvard Bioscience Inc, Annual Ratios (Cont...2)
Harvard Bioscience Inc, Interim Ratios
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Harvard Bioscience Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Harvard Bioscience Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Harvard Bioscience Inc, Performance Chart (2016 - 2020)
Harvard Bioscience Inc, Ratio Charts
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Harvard Bioscience Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021


More Publications